GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,440.00
+35.00 (0.79%)
At close: Jun 27, 2025, 3:30 PM KST
13.12%
Market Cap 38.23B
Revenue (ttm) 85.65B
Net Income (ttm) 2.93B
Shares Out 8.61M
EPS (ttm) 340.34
PE Ratio 13.05
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 190,254
Average Volume 115,152
Open 4,405.00
Previous Close 4,405.00
Day's Range 4,315.00 - 4,575.00
52-Week Range 3,015.00 - 4,790.00
Beta 0.47
RSI 68.28
Earnings Date Aug 14, 2025

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 41
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2024, GeneBioTech Co. ,Ltd's revenue was 82.96 billion, an increase of 4.38% compared to the previous year's 79.48 billion. Earnings were 2.87 billion, an increase of 10.57%.

Financial Statements

News

There is no news available yet.